TRCT
BTCY

Tower Research Capital (TRC)’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Tower Research Capital (TRC)’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,722
Closed -$6.95K – 6111
2024
Q2 		$6.95K Buy
7,722
+6,198
+407% +$7.14K ﹤0.01% 4517
2024
Q1 		$2.26K Sell
1,524
-4,123
-73% -$4.47K ﹤0.01% 5085
2023
Q4 		$6.49K Buy
5,647
+2,474
+78% +$3.3K ﹤0.01% 4732
2023
Q3 		$6.79K Buy
3,173
+113
+4% +$273 ﹤0.01% 4555
2023
Q2 		$11.7K Buy
3,060
+739
+32% +$2.76K ﹤0.01% 3945
2023
Q1 		$6K Buy
2,321
+382
+20% +$1.57K ﹤0.01% 4906
2022
Q4 		$5K Buy
1,939
+474
+32% +$2.62K ﹤0.01% 4942
2022
Q3 		$7K Buy
1,465
+873
+147% +$6.13K ﹤0.01% 4953
2022
Q2 		$6K Buy
592
+374
+172% +$3.26K ﹤0.01% 4985
2022
Q1 		$3K Buy
218
+201
+1,182% +$3.49K ﹤0.01% 5446
2021
Q4 		$0 Buy
+17
New +$401 ﹤0.01% 6688

Other funds holding BTCY

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Tower Research Capital (TRC)'s BTCY Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 7,722 shares — an estimated $6.95K sold.

Tower Research Capital (TRC) first reported a position in BTCY in Q4 2021 and held it in 11 quarters. The position peaked at $11.7K in Q2 2023. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • Tower Research Capital (TRC) reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,722 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $6.95K.
  • Tower Research Capital (TRC) first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Biotricity, Inc. Common Stock position peaked at $11.7K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.